Fig. 1From: Tolvaptan therapy of Chinese cirrhotic patients with ascites after insufficient diuretic routine medication responses: a phase III clinical trialChange in body weight from baseline at each time point in the placebo, 7.5 mg and 15 mg tolvaptan groups. Data are expressed as the mean ± standard deviation (SD). The comparison between the tolvaptan and placebo groups was performed using ANOVA. End of treatment (EOT)Back to article page